LAURA DELLORUSSO: Open Payments
NPI 1447426796 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 5 payments from 5 companies in 2025. Trend: 2023 $136 · 2024 $150 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $135 |
| AstraZeneca Pharmaceuticals LP | 1 | $130 |
| Novo Nordisk Inc | 1 | $110 |
| Kestra Medical Technology Services, Inc. | 1 | $82 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $45 |
Products named: LEQVIO, WAINUA, Ozempic, Assure WCD, LifeVest.
Industry payments across NJ — which companies pay providers there.
